
Stimulating insulin secretion from the pancreas when glucose levels are elevated
Inhibiting glucagon release, which helps prevent excess glucose production by the liver
Slowing gastric emptying, leading to slower digestion and steadier blood sugar levels

Available as Victoza (for diabetes) and Saxenda (for weight management)
Available as Ozempic (for diabetes) and Wegovy (for weight management)
Available as Mounjaro (for diabetes and weight management)
GLP-1 agonists help regulate blood sugar by stimulating insulin production and limiting glucose output from the liver. These medications are often prescribed when oral diabetes medications like metformin are not enough to control blood sugar levels. Some GLP-1 agonists have been shown to help reduce cardiovascular risks in people with type 2 diabetes and heart disease.
For those without diabetes, medications like Saxenda and Wegovy are FDA-approved for weight loss. These GLP-1 agonists help promote satiety and curb appetite, making it easier for patients to reduce calorie intake without feeling hungry. Clinical trials show that combining GLP-1 therapy with lifestyle modifications can result in substantial and lasting weight loss.
GLP-1 receptor agonists help regulate blood sugar by stimulating insulin release and suppressing glucagon secretion after eating. This dual mechanism reduces post-meal blood sugar spikes and improves overall glycemic control. Because the response is glucose-dependent, there is a significantly lower risk of hypoglycemia compared to many traditional treatments for diabetes.
GLP-1 therapy is highly effective for supporting long-term weight management. By slowing gastric emptying and triggering feelings of fullness, GLP-1 agonists help reduce appetite and make it easier to cut down on calorie consumption. Clinical studies have proven that drugs like liraglutide, semaglutide, and tirzepatide lead to significant and lasting weight loss when used alongside healthy lifestyle changes..



GLP-1/GIP co-agonists stimulate both GLP-1 and GIP receptors to enhance insulin release and appetite control. Their dual mechanism makes them an effective treatment for managing blood sugar and reducing hunger in people with metabolic conditions.
GLP-1/glucagon co-agonists target both GLP-1 and glucagon receptors, aiming to improve weight loss and energy metabolism while preserving lean muscle mass.

